The interstitial lung disease (ILD) unit at Royal Brompton Hospital is the largest unit of its kind in Europe with more than 4,000 patients, and is the only unit in the UK dedicated to the management of patients with fibrosing lung disease.
In the past decade, Royal Brompton Hospital has been at the forefront of the developments made in the diagnosis and treatment of ILD.
Read more about the conditions associated with interstitial lung disease
Meet the ILD team
Professor Athol Wells (academic lead for ILD)
Dr Felix Chua (clinical lead for ILD)
Dr Toby Maher
Dr Elizabeth Renzoni
Clinical nurse specialist
Senior research nurse
Read about patient and public involvement in our interstitial lung disease research in the Respiratory BRU.